Global pessary market was worth USD 239.9 millions in 2020. It is expected to grow at 9.2% CAGR between 2021 and 2028. Market growth is expected to be driven by increasing prevalence of pelvic organ dysfunction, an aging population, easier product availability, lifestyle changes, and the rapid development of non-invasive treatment options. Patients with low nutritional status are more likely to experience stress urine incontinence, which can lead to weakening of the pelvic muscles. In the coming years, there will be a significant increase in demand for advanced pelvic supports devices.
Because they are simple, inexpensive, and reliable, vaginal pessaries have become a popular treatment option for incontinence and organ prolapse. These factors result in a higher satisfaction rate for patients than other treatment options. Vaginal pessaries can now be considered first-line treatment for pelvic prolapse or stress urinary incontinence. Women of all ages are affected by Pelvic Organ Prolapse. Older women are more likely to develop POP complications. The US Food and Drug Administration has found that the number of POP-positive women is expected to increase by 46 percent between 2050 and 4.9 million by 2050.
As a temporary solution to delayed elective surgery during the COVID-19 epidemic, pessaries were favored. The overall demand for COVID-19 was much lower than the previous wave. This can be attributed a decrease of footfall in hospitals and clinics during the pandemic. Production during the first wave COVID-19 was directly affected by the lockdown and restrictions on gathering. The production units reopened in the third quarter 2020. Patient discomfort and fear of side effects are factors that can impact the adoption of vaginal saline. These issues were addressed by regulatory agencies like the FDA and NICE who have created new guidelines for manufacturers.
The market will be boosted by several factors, including frequent introductions of new products, a heavy focus on R&D from market players and universities as well as geographic expansion by key players and a number of government initiatives. Cosm Medical Corporation was approved by Health Canada Investigational Testing Authorization for its clinical study of its product gynethotics. This allows for the creation of customized gynecological protheses. Cosm creates a custom pessary that is based on each patient's anatomy and lifestyle using a modernized pelvic measurement system with novel ultrasound imaging technology.
In 2020, the largest revenue share was 58.9% for the ring pessary segment. This segment will see a significant CAGR over the forecast period due to factors like ease of use and patient comfort. Ring pessaries are suitable for all stages in POP. Ring pessaries are preferred by clinicians because they can be easily inserted and removed. They are most effective during the first stages of prolapse but can also be used at any stage.
Other pessaries in widespread use include the shaatz and oval pessaries, shelf, and cube. While they are useful for advanced prolapse, other support pessaries are less effective and more difficult to use. This device uses suction technology to lift prolapsed areas. Silicone is a highly compatible material and silicone makes up the majority of pessaries on the market. They are non-allergenic, durable, washable in hot water, and easy to replace. There are many factors that determine which type of pessary you should use, such as the degree and type of prolapse.
Hospitals dominated the vaginal market for pessaries and had the largest revenue share at 44.2% in 2020. This is due to the increased demand for pessaries in bedridden and post-operative patients. The segment is growing due to increased awareness of organ prolapse and urinary incontinence. Private insurances also include pessaries. Hospitals are now using minimally invasive methods to place a pessary in order to speed recovery and reduce post-operative complications.
The fastest CAGR in the pessary market is expected to be 9.8% for the clinic segment during the forecast period. This could be due to the affordability of pessary fitting, shorter hospital stays, and greater convenience for the elderly. The growth of ambulatory clinics is also predicted to be significant during the forecast period. There will be a greater awareness of ambulatory centers, which will spur their growth.
North America was the dominant market, accounting for 41.1% of the total revenue in 2020. Market impact is high due to factors like an aging population, lifestyle changes that can cause hormonal disruptions and the increasing prevalence of pelvic organ proslapse. The US Department of Health and Human Services estimates that 3.3 million American women have suffered from pelvic organ prolapse. This number is likely to rise to 4.9 millions by 2050 as a result of aging.
The Asia Pacific market for pessary will experience an exponential growth rate over the forecast period. Emerging economies, an aging population and increased healthcare awareness are expected to drive the fastest growth in the region's market. Geriatrics are more susceptible to POP and urinary inconsistency. This market is large, with India, China, and Japan being the main regional providers. Another important factor driving the market is the growth of medical tourism.
Market competition is fierce, with many domestic and international players. Market players have taken key strategic initiatives such as new product development and mergers, acquisitions, partnership, collaboration. Dr. Arabin GmbH, a German-based pessary manufacturer, created the Arabin Cerclage to help support the cervical area of pregnant women at high risk of preterm birth. The pessary market is dominated by the following:
CooperSurgical Inc.
Bliss GVS Pharma
MedGyn
Panpac Medical Corporation
Bioteque America
Personal Corporation
Dr. Arabin GmbH & Co. KG
Integra Lifesciences
Wallach Surgical Devices
Up Market Research published a new report titled “Pessary Market research report which is segmented by Type (Ring, Donut, Gellhorn), by End-use (Clinics, Hospitals, Ambulatory Surgical Centers), By Players/Companies Integra Lifesciences, Bioteque America, Wallach Surgical Devices, MedGyn, Dr Arabin GmbH & Co KG, Bliss GVS Pharma, Personal Medical Corporation, Panpac Medical Corporation, CooperSurgical Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Pessary Market Research Report |
By Type | Ring, Donut, Gellhorn |
By End-use | Clinics, Hospitals, Ambulatory Surgical Centers |
By Companies | Integra Lifesciences, Bioteque America, Wallach Surgical Devices, MedGyn, Dr Arabin GmbH & Co KG, Bliss GVS Pharma, Personal Medical Corporation, Panpac Medical Corporation, CooperSurgical Inc |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 244 |
Number of Tables & Figures | 171 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type (Ring, Donut, Gellhorn), by End-use (Clinics, Hospitals, Ambulatory Surgical Centers).
Pessary Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Pessary Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Pessary Market Report:
Some other reports from this category!